Kyushu University Academic Staff Educational and Research Activities Database
List of Presentations
Hideya Onishi Last modified dateļ¼š2023.11.22

Associate Professor / Department of Cancer Therapy and Research / Department of Advanced Medical Initiatives / Faculty of Medical Sciences


Presentations
1. Onishi H, Fujimura A, Yamasaki A, Development of a non-antibody type immune check point inhibitor targeting PTPN3 expressed in activated lymphocytes, AACR 2020, 2020.04.
2. Akio Yamasaki, Satoko Koga, Shu Ichimiya, Kazunori Nakayama, Akiko Fujimura, Yasuhiro Oyama, Yutaka Fujioka, Hideya Onishi, Protein tyrosine phosphatase non-receptor type 3 (PTPN3) could be a new therapeutic target for pancreatic cancer, ESMO 2019, 2019.09.
3. Saeki K, Onishi H, Oda Y, Nakamura M, FAM115c that regulates proliferation and invasion under hypoxia could be a predictive biomarker for pancreatic cancer, ESMO 2018, 2018.10.
4. Kawamoto M, Onishi H, Nakamura M, C4orf47 contributes to the induction of malignant phenotypes in pancreatic cancer, ESMO Asis 2017, 2017.11.
5. Makoto Kawamoto, Hideya Onishi, Keigo Ozono, Akio Yamasaki, Masafumi Nakamura, TrkB-mediated signaling contributes to malignant phenotypes of gallbladder cancer, AACR2017, 2017.04.
6. Hideya Onishi, Akiko Fujimura, Yasuhiro Oyama, Makoto Kawamoto, Akio Yamasaki, Masafumi Nakamura, Takashi Morisaki, Hedgehog signaling augments PDL-1 expression in cancer cells under hypoxic condition to inhibit anti-tumor effects by activated lymphocytes, AACR 2017, 2017.04.
7. Akio Yamasaki, Hideya Onishi, Masafumi Nakamura, Recombination signal binding protein for immunoglobulin-kappa-J region
(RBPJ) and Mastermind-like 3 (MAML3) are potential therapeutic targets for
pancreatic cancer, ESMO ASIA 2016, 2016.12.
8. Makoto Kawamoto, Hideya Onishi, Keigo Ozono, Akio Yamasaki, Akira Imaizumi, Masafumi Nakamura, TrkB/BDNF signaling promotes EMT mediated invasiveness and is a potential therapeutic target for gallbladder cancer, ESMO2016, 2016.10.